Abstract
ROLE OF SHAMAN TREATMENT ALONG WITH AHAR VIHAR IN DYSLIPIDEMIA (MEDOROGA)

Dr. Rajneesh Pathak*

ABSTRACT

Dyslipidemia is an emerging serious health abnormality associated with co-morbidities including CVD that continues to be the leading cause of death worldwide. It is characterized by an increase in cholesterol, triglycerides, LDL levels, and a decrease in HDL levels. In present era, the way of life has changed drastically due to inactive sedentary life & excessive carbohydrate & fatty diet throughout the world. Because of these factors, the accumulation of Fat (Meda-Dhatu) occurs immensely. Dyslipidemia is the main disposing factor for the atherosclerosis, and the atherosclerosis is the main pathogenesis factor for cardiovascular disease. In Ayurvedic view, dyslipidemia is considered under Medoroga & can be considered similar to aggravated Dusta Meda Dhatu in the body which is caused due to hypo function of Medo-Dhatwagni leading to Medovaha Srotodusti Vikara. Aim & Objective: To study the various formulations and drugs described for Medoroga (Dyslipidemia) as Shaman Chikitsa in Ayurveda along with proper Aahar & vihar. Materials and Methods: The classical texts of Ayurveda and modern medicine, Journals, and Research articles from Google Scholar, PubMed, etc. were selected for the study. Observations and Discussion: The research studies conducted on guggulu formulations, Arogyavardhini vati, Triphala, Trikatu, Arjun, Yava & many more preparations showed significant improvement in lipid levels which may be due to their Katu, Kashaya Rasa, Ushna, Teekshna Guna and Lekhana, Deepana, Pachana properties that help in reducing aggravated Kapha and Meda along with Nidan-parivarjana i.e avoidance of improper Aahar vihar sevan. Conclusion: Dyslipidemia can be effectively managed with various formulations given in Ayurveda with proper Aahar vihar sevan.

Keywords: Dyslipidemia, Medoroga, Shaman Chikitsa, proper Aahar & vihar.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: APRIL ISSUE PUBLISHED

    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT